Merck
  • Home
  • Search Results
  • PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.

PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.

Experimental cell research (2013-04-23)
Weirong Wang, Qinqin Lin, Rong Lin, Jiye Zhang, Feng Ren, Jianfeng Zhang, Meixi Ji, Yanxiang Li
ABSTRACT

The ligand-activated transcription factor peroxisome proliferator-activated receptor-α (PPARα) participates in the regulation of cellular inflammation. More recent studies indicated that sirtuin1 (SIRT1), a NAD(+)-dependent deacetylase, regulates the inflammatory response in adipocytes. However, whether the role of PPARα in inflammation is mediated by SIRT1 remains unclear. In this study, we aimed to determine the effect of PPARα agonist fenofibrate on the expressions of SIRT1 and pro-inflammatory cytokine CD40 and underlying mechanisms in 3T3-L1 adipocytes. We found that fenofibrate inhibited CD40 expression and up-regulated SIRT1 expression in tumor necrosis factor-α (TNF-α)-stimulated adipocytes, and these effects of fenofibrate were reversed by PPARα antagonist GW6471. Moreover, SIRT1 inhibitors sirtinol/nicotinamide (NAM) or knockdown of SIRT1 could attenuate the effect of fenofibrate on TNF-α-induced CD40 expression in adipocytes. Importantly, NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) augmented the effect of fenofibrate on CD40 expression in adipocytes. Further study found that fenofibrate decreased the expression of acetylated-NF-κB p65 (Ac-NF-κB p65) in TNF-α-stimulated adipocytes, and the effect of fenofibrate was abolished by SIRT1 inhibition. In addition, fenofibrate up-regulated SIRT1 expression through AMPK in TNF-α-stimulated adipocytes. Taken together, these findings indicate that PPARα agonist fenofibrate inhibits TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
烟酰胺, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
L-酪氨酸, reagent grade, ≥98% (HPLC)
Supelco
烟酰胺, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
烟酰胺, ≥99.5% (HPLC)
Sigma-Aldrich
吡咯烷二硫代氨基甲酸铵, ~99%
SAFC
L-酪氨酸
Sigma-Aldrich
烟酰胺, ≥98% (HPLC), powder
Sigma-Aldrich
L-酪氨酸, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 99.0-101.0%
Sigma-Aldrich
烟酰胺, meets USP testing specifications
Sigma-Aldrich
L-酪氨酸, BioUltra, ≥99.0% (NT)
Supelco
尼克酰胺(烟酰胺), analytical standard
Sigma-Aldrich
吡咯烷二硫代氨基甲酸铵, purum p.a., ≥98.0% (NT)
Sigma-Aldrich
非诺贝特, ≥99%, powder
Supelco
非诺贝特, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-酪氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
烟酰胺, ≥98.5% (HPLC)
烟酰胺, European Pharmacopoeia (EP) Reference Standard
Supelco
烟酰胺 (维生素B3)标准液 CRM 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
L-酪氨酸, FG
Supelco
L-酪氨酸, certified reference material, TraceCERT®
非诺贝特, European Pharmacopoeia (EP) Reference Standard